There is the inbetween option of taking the drug through one or more phase 3s and then licensing without going all the way to market. In that case the responsibility for distribution would fall on who they licensed to and the deal would be more sizeable having progressed the compound further. I think that would be what Neuren are thinking as taking on the distribution aspect is a big step that current management aren't likely to have any experience.
- Forums
- ASX - By Stock
- NEU
- Neuren Media and Analyst Coverage
Neuren Media and Analyst Coverage, page-1141
-
-
- There are more pages in this discussion • 133 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$19.10 |
Change
-0.290(1.50%) |
Mkt cap ! $2.440B |
Open | High | Low | Value | Volume |
$19.55 | $19.65 | $18.88 | $3.518M | 183.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 770 | $19.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.11 | 367 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 111 | 19.100 |
8 | 361 | 19.090 |
6 | 380 | 19.080 |
5 | 554 | 19.070 |
5 | 409 | 19.060 |
Price($) | Vol. | No. |
---|---|---|
19.110 | 43 | 4 |
19.120 | 345 | 15 |
19.130 | 317 | 6 |
19.140 | 225 | 3 |
19.150 | 528 | 6 |
Last trade - 12.17pm 31/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
Previous Video
Next Video
SPONSORED BY The Market Online